David Howe

636 total citations
11 papers, 511 citations indexed

About

David Howe is a scholar working on Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, David Howe has authored 11 papers receiving a total of 511 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pathology and Forensic Medicine, 6 papers in Pulmonary and Respiratory Medicine and 5 papers in Genetics. Recurrent topics in David Howe's work include Lymphoma Diagnosis and Treatment (6 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Lung Cancer Treatments and Mutations (3 papers). David Howe is often cited by papers focused on Lymphoma Diagnosis and Treatment (6 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Lung Cancer Treatments and Mutations (3 papers). David Howe collaborates with scholars based in United States, United Kingdom and Canada. David Howe's co-authors include Scot Sorensen, D F Moravec, Mark Hutchins, Monroe D. Dowling, Jamés O. Armitage, J A Mailliard, Dennis D. Weisenburger, Julie M. Vose, Philip J. Bierman and Patrick S. Johnson and has published in prestigious journals such as Journal of Clinical Oncology, CHEST Journal and The American Journal of Medicine.

In The Last Decade

David Howe

11 papers receiving 496 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Howe United States 8 395 197 159 125 95 11 511
Hoon‐Gu Kim South Korea 18 194 0.5× 321 1.6× 28 0.2× 60 0.5× 192 2.0× 42 713
Nael Da’as Israel 10 163 0.4× 63 0.3× 38 0.2× 133 1.1× 73 0.8× 23 523
M. Tomirotti Italy 14 95 0.2× 498 2.5× 75 0.5× 66 0.5× 539 5.7× 32 904
D. Baer United States 6 86 0.2× 130 0.7× 19 0.1× 59 0.5× 71 0.7× 7 372
M. Weinblatt United States 13 62 0.2× 57 0.3× 41 0.3× 141 1.1× 38 0.4× 40 837
Christopher Enny United States 14 178 0.5× 250 1.3× 72 0.5× 255 2.0× 32 0.3× 21 962
Süleyman Alıcı Türkiye 12 102 0.3× 258 1.3× 20 0.1× 30 0.2× 136 1.4× 40 540
R. Vriesendorp Netherlands 11 80 0.2× 84 0.4× 24 0.2× 24 0.2× 121 1.3× 15 570
Marika Rasschaert Belgium 12 84 0.2× 261 1.3× 12 0.1× 51 0.4× 109 1.1× 32 545
Z. R. Desai United Kingdom 10 65 0.2× 194 1.0× 26 0.2× 55 0.4× 35 0.4× 15 397

Countries citing papers authored by David Howe

Since Specialization
Citations

This map shows the geographic impact of David Howe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Howe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Howe more than expected).

Fields of papers citing papers by David Howe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Howe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Howe. The network helps show where David Howe may publish in the future.

Co-authorship network of co-authors of David Howe

This figure shows the co-authorship network connecting the top 25 collaborators of David Howe. A scholar is included among the top collaborators of David Howe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Howe. David Howe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Howe, David, et al.. (2021). Transoral robotic resection of a lingual thyroid: a novel treatment for obstructive sleep apnoea. BMJ Case Reports. 14(9). e241412–e241412. 2 indexed citations
2.
Islam, S.M. Rafiqul, et al.. (2014). Hypocalcaemia following total thyroidectomy: early post-operative parathyroid hormone assay as a risk stratification and management tool. The Journal of Laryngology & Otology. 128(3). 274–278. 13 indexed citations
4.
Howe, David, et al.. (2011). Is Routine Nasoendoscopy Warranted in Epistaxis Patients after Removal of Nasal Packing?. Allergy & Rhinology. 2(1). 12–5. 1 indexed citations
5.
Gao, Hongying, et al.. (2007). Method for rapid metabolite profiling of drug candidates in fresh hepatocytes using liquid chromatography coupled with a hybrid quadrupole linear ion trap. Rapid Communications in Mass Spectrometry. 21(22). 3683–3693. 29 indexed citations
6.
Vose, Julie M., P. J. Bierman, J R Anderson, et al.. (1991). CHLVPP chemotherapy with involved-field irradiation for Hodgkin's disease: favorable results with acceptable toxicity.. Journal of Clinical Oncology. 9(8). 1421–1425. 20 indexed citations
7.
Armitage, Jamés O., Philip J. Bierman, Dennis D. Weisenburger, et al.. (1989). Salvage therapy for relapsed or refractory non-Hodgkin's lymphoma utilizing autologous bone marrow transplantation. The American Journal of Medicine. 87(3). 285–288. 44 indexed citations
8.
Vose, Julie M., DD Weisenburger, D F Moravec, et al.. (1988). Ch1VPP—An Effective and Well-Tolerated Alternative to MOPP Therapy for Hodgkinʼs Disease. American Journal of Clinical Oncology. 11(4). 423–426. 14 indexed citations
9.
Vose, Julie M., Jamés O. Armitage, Dennis D. Weisenburger, et al.. (1988). The importance of age in survival of patients treated with chemotherapy for aggressive non-Hodgkin's lymphoma.. Journal of Clinical Oncology. 6(12). 1838–1844. 225 indexed citations
10.
Armitage, Jamés O., et al.. (1988). Pulmonary Emboli in Patients Receiving Chemotherapy for Non-Hodgkin's Lymphoma. CHEST Journal. 94(3). 589–594. 6 indexed citations
11.
Armitage, Jamés O., DD Weisenburger, Mark Hutchins, et al.. (1986). Chemotherapy for diffuse large-cell lymphoma--rapidly responding patients have more durable remissions.. Journal of Clinical Oncology. 4(2). 160–164. 132 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026